Insights
Ethical Goals and Design Criteria for ‘Fair Access” to Drugs in the US Health Care System
31 March 2021
In the contentious debate around US drug prices, less well understood is: if the price of a drug is a fair, value-based, price, how we assess…
Time to Tackle the Challenges around Combination Therapies for Cancer
29 March 2021
A new Editorial reviews three solutions to the price and value challenge to reimbursing combination products. Higher thresholds are not justifiable. Evidence to support use of…
Efficiency Measurement in Primary Care: Time to Overcome the Challenges and Achieve Some Gains
10 March 2021
Why is the measurement of efficiency in health care so important, but equally challenging? And why is it especially so in primary care? This blog provides…
International Women’s Day: Why We #Choosetochallenge
8 March 2021
On International Women’s Day, OHE recognises the ongoing need to call out gender inequality, celebrates the achievements made in the health economics community, and reflects on why gender diversity is a ‘no-brainer’ for us as an organisation.
Does Government Funding Increase Public Sector Development of New Medicines?
5 March 2021
A new paper, published last week in Applied Economics, by Dimitrios Kourouklis, Senior Economist at OHE, looks at the question of whether government funding increases public…
‘HispaNICE’: the Creation of an ‘Independent Authority for the Evaluation of Health Practices and Policies’ Gathers Momentum
24 February 2021
This blog summarises an initiative taken by more than 300 health economists and experts in support of the creation of an independent health technology assessment agency…
OHE at HESG Winter 2021
11 January 2021
Members from the team at OHE attended the Health Economists’ Study Group (HESG) Winter 2021 Meeting, hosted online by the Centre for Health Economics in London,…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
Histology independent therapies are changing the picture of cancer treatment and in so doing don’t ‘fit the frame’ of value assessment. What are the key challenges…
A NICE Wind of Change? The What and So What of the NICE Methods Consultation
7 December 2020
This blog post summarises some of the more notable changes put forward in NICE’s methods consultation (November – December 2020), and comments on their potential consequences.…